IPCA Labs Fact Sheet, IPCA Labs Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Fact Sheet    (IPLB)


REVEALED: 3 "Super Smallcaps" You Didn't Know About


Here is the latest financial fact sheet of IPCA Labs. For more details, see the IPCA Labs quarterly results and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

IPCA LABS Price History

Price Rs 2,412.5
Mkt Cap Rs m 306,024
Vol '000 16.2
P/E X 30.3
P/CF X 22.5
EPS (TTM) Rs 79.7
% ch % -3.4
No. of shares m 126.85
% ch week % -7.0
% ch 1-mth % -2.2
% ch 12-mth % 12.3
52 week H/L Rs 2,767.1/1,786.1
(As on Sep 20, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

IPCA LABS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
IPCA LABS EQUITY SHARE DATA
High Rs6436951,0421,6162,456 
Low Rs4024005908441,371 
Sales per share (Unadj.) Rs245.7256.1294.3363.2423.3 
Earnings per share (Unadj.) Rs16.119.335.148.490.6 
Diluted earnings per shareRs16.019.235.048.290.6 
Cash flow per share (Unadj.) Rs29.833.449.665.0107.1 
Dividends per share (Unadj.) Rs1.001.003.005.008.00 
Adj. dividends per shareRs0.990.992.994.988.00 
Avg Dividend yield %0.20.20.40.40.4 
Book value per share (Unadj.) Rs194.6213.0247.1286.2370.6 
Adj. book value per shareRs193.6211.9246.1285.0370.6 
Shares outstanding (eoy) m126.20126.20126.35126.35126.85 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x2.12.12.83.44.5 
Avg P/E ratio x32.528.423.225.421.1 
P/CF ratio (eoy) x17.516.416.518.917.9 
Price / Book Value ratio x2.72.63.34.35.2 
Dividend payout %6.25.28.510.38.8 
Avg Mkt Cap Rs m65,93969,119103,110155,407242,728 
No. of employees `000NANANANANA 
Total wages/salary Rs m6,9607,3597,8749,21210,136 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
IPCA LABS INCOME DATA
Net Sales Rs m31,00232,32037,18245,89453,699 
Other income Rs m5485817478651,292 
Total revenues Rs m31,54932,90037,92946,75954,991 
Gross profit Rs m4,1544,4206,7838,90514,812 
Depreciation Rs m1,7301,7771,8242,1052,092 
Interest Rs m269276222198123 
Profit before tax Rs m2,7032,9485,4837,46713,890 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6755111,0421,3532,401 
Profit after tax Rs m2,0282,4374,4406,11411,488 
Gross profit margin %13.413.718.219.427.6 
Effective tax rate %25.017.319.018.117.3 
Net profit margin %6.57.511.913.321.4 
IPCA LABS BALANCE SHEET DATA
Current assets Rs m17,41819,45523,77828,55734,370 
Current liabilities Rs m9,55910,07610,97513,26411,331 
Net working cap to sales %25.329.034.433.342.9 
Current ratio x1.81.92.22.23.0 
Inventory Days Days3024253649 
Debtors Days Days59686776 
Net fixed assets Rs m22,17721,70121,71124,02126,295 
Share capital Rs m252252253253254 
"Free" reserves Rs m24,30026,63030,97135,90346,763 
Net worth Rs m24,55326,88331,22436,15547,017 
Long term debt Rs m3,5172,3401,4091,030365 
Total assets Rs m39,59541,15645,48852,57860,664 
Interest coverage x11.011.725.738.8114.2 
Debt to equity ratio x0.10.1000 
Sales to assets ratio x0.80.80.80.90.9 
Return on assets %5.86.610.312.019.1 
Return on equity %8.39.114.216.924.4 
Return on capital %10.611.017.520.629.6 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m15,61715,64217,30821,43827,172 
Fx outflow Rs m4,5714,8846,2667,6947,949 
Net fx Rs m11,04610,75911,04213,74319,223 
IPCA LABS CASH FLOW
From Operations Rs m 2,819 3,411 5,010 5,704 10,901 
From Investments Rs m -1,488 -1,354 -1,651 -5,097 -5,207 
From Financial Activity Rs m -1,591 -1,304 -1,832 -1,365 -3,058 
Net Cashflow Rs m -260 753 1,528 -755 2,636 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 46.3%
Institution 43.2%
Non-Institution 10.6%
Total 100.0%
Free Float 53.7%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF 48 Kandivli Industrial Estate, Kandivli (West), Mumbai - 400067
E-MAIL investors@ipca.com WEB www.ipca.com
TEL 022- 66474444/62106050 FAX 022- 62105005
SECTOR PHARMACEUTICALS GROUP Ipca Laboratories Group
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
AUDITOR Natvarlal Vepari & Co.
CHM: Premchand Godha (MD) COMP SEC: Harish P. Kamath (VP - Legal) YEAR OF INC: 1949 BSE CODE: 524494 FV (Rs): 2 DIV YIELD (%): 0.3

Read: IPCA LABS 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   FREDUN PHARMA  DECCAN HEALTH CARE  AJANTA PHARMA  CADILA HEALTHCARE  ABBOTT INDIA  

Compare IPCA LABS With:   FREDUN PHARMA  DECCAN HEALTH CARE  AJANTA PHARMA  CADILA HEALTHCARE  ABBOTT INDIA  




Today's Market

5 Factors Why Stock Markets Crashed, Dish TV's AGM, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended deep in the red yesterday. Tracking a rout in the global markets, benchmark indices tumbled for the second day.

Views on news

IPCA LABS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of IPCA LABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of IPCA LABS. Also includes updates on the valuation of IPCA LABS.

IPCA LABS Announces Quarterly Results (1QFY22); Net Profit Down 30.8% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, IPCA LABS has posted a net profit of Rs 3 bn (down 30.8% YoY). Sales on the other hand came in at Rs 16 bn (up 2.0% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS